MeSH D006192 - haemophilus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amoxicillin, Clavulanic acid | Amoxicillin Clavulanate Potassium | 2004-05-25 | |||
| Levofloxacin | Levofloxacin | 2011-06-20 | ||||
| Ofloxacin | Ofloxacin | 2003-09-02 | ||||
| Glenmark Pharmaceuticals | Levofloxacin | Levofloxacin | 2011-06-20 | |||
| Mylan | Levofloxacin | Levofloxacin | 2011-06-20 | |||
| Rifampin | Rifampin | 2008-05-22 | ||||
| Rising Pharmaceuticals | Amoxicillin, Lansoprazole, Clarithromycin | Lansoprazole, Amoxicillin Clarithromycin | 2016-10-07 | |||
| Levofloxacin | Levofloxacin | 2010-12-20 | ||||
| NATCO Pharma | Levofloxacin | Levofloxacin | 2011-06-20 | |||
| Johnson & Johnson | Ofloxacin | Floxin | 1990-12-28 | |||
| Levofloxacin | Levaquin | 1996-12-20 | ||||
| GSK | Ticarcillin, Clavulanic acid | Timentin | 1986-12-19 | |||
| Lupin Research | Levofloxacin | Levofloxacin | 2011-06-20 | |||
| Rifampin | Rifampin | 2013-08-21 |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%43/43
Approved: 43Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use